In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation

Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: Preparation and evaluation

(2011) Feng Guo et al.   ARCHIVES OF PHARMACAL RESEARCH

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

(2011) Alfonso Dueñas-González et al.   JOURNAL OF CLINICAL ONCOLOGY

Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin’s lymphoma - EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)

(2010) Igor Aurer et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

(2010) Stefan Madajewicz et al.   INVESTIGATIONAL NEW DRUGS

Formulation Development and Bioavailability Evaluation of a Self-Nanoemulsified Drug Delivery System of Oleanolic Acid

(2009) Jia Xi et al.   AAPS PHARMSCITECH

Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study

(2008) S. A. Veltkamp et al.   CLINICAL CANCER RESEARCH

Modulation of Gemcitabine (2',2'-Difluoro-2'-Deoxycytidine) Pharmacokinetics, Metabolism, and Bioavailability in Mice by 3,4,5,6-Tetrahydrouridine

(2008) J. H. Beumer et al.   CLINICAL CANCER RESEARCH